Related Experiment Video
Updated: Feb 22, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Diabetes-Associated Biobanking: More Topical Than Ever?
Katharina Lydia Kynast1, Nadine Volk1, Thomas Fleming2
1Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
A new diabetes-specific Biomaterialbank (BMB) preserves human specimens to advance research on reactive metabolites and diabetic complications. This initiative supports translational research, aiming for improved diagnostics and patient care.
Area of Science:
- Biomedical Research
- Endocrinology
- Pathology
Background:
- Rising diabetes prevalence and complications necessitate faster clinical translation of research findings.
- Reactive metabolites (RM) are implicated as a cause of long-term diabetic complications.
- There is a need for high-quality human biomaterials to support translational and clinical diabetes research.
Purpose of the Study:
- To establish and describe the first nationwide diabetes-specific Biomaterialbank (BMB) for collecting and preserving human diabetic specimens.
- To support researchers investigating the role of reactive metabolites in diabetic complications.
- To highlight the importance of biobanking for high-quality human biomaterial and sustainable diabetes research.
Main Methods:
- Establishment of a nationwide diabetes-specific Biomaterialbank (BMB) at the University Hospital Heidelberg.
- Permanent preservation of solid and liquid human diabetic specimens, both retrospectively and prospectively.
- Characterization and provision of diabetic specimens to researchers.
Main Results:
- The BMB provides a crucial resource for investigating the role of reactive metabolites in diabetic complications.
- The biobanking procedures ensure high-quality human biomaterial for research.
- Preservation of rare, non-neoplastic specimens supports basic investigation and data generation.
Conclusions:
- The diabetes-specific BMB is pivotal for advancing translational and clinical diabetes research.
- Understanding metabolic imbalance and its link to diabetes progression and complications can lead to innovative diagnostics and therapeutics.
- This initiative fortifies the sustainability of diabetes research and aims to improve patient care.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer

